Latest News | Eisai Co., Ltd.

December 4, 2023

Sustainability "Scientists Discuss the Development of a New Treatment for the Elimination of Mycetoma"
November 8, 2023

IR “Second Quarter Financial Results Briefing for the Fiscal Year Ending March 31, 2024 [Material, Webcast]”
November 7, 2023

IR “Second Quarter Financial Report for the Fiscal Year Ending March 31, 2024”
November 6, 2023

Sustainability "Lymphatic Filariasis Elimination Activities in Myanmar ー Message from a DEC Manager"
October 27, 2023

Sustainability "Eisai Participated in “RECYCLE TO END POLIO”, a Campaign Aiming for a Polio-Free World by Recycling PET Bottle Caps"
October 26, 2023

Thursday, October 26, 2023 06:25 a.m. (JST)
CTAD Conference: Late-Breaking Symposium 4 – Lecanemab for early Alzheimer’s Disease: Long-Term Outcomes, Predictive Biomarkers, and Novel Subcutaneous Administration (Material, LIVE)
October 17, 2023

IR “Value Creation Report 2023”
October 11, 2023

IR “Human Capital Report 2023”
October 5, 2023

Sustainability "Eisai CEO Haruo Naito Delivered Speech at G7 Health Follow-up Side Event"